FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/062064 [Registered on: 30/01/2024] Trial Registered Prospectively
Last Modified On: 01/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   The effect of melatonin pre-treatment on the consumption of inhaled anaesthetic in children undergoing planned surgery. 
Scientific Title of Study   To evaluate the effect of melatonin premedication on Bispectral Index guided sevoflurane consumption in pediatric surgery: A randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pulkit Johar 
Designation  Junior Resident 
Affiliation  AIIMS Rishikesh 
Address  Department of Anaesthesiology and Critical Care AIIMS Rishikesh Virbhadra Road Rishikesh

Dehradun
UTTARANCHAL
249203
India 
Phone  9877307543  
Fax    
Email  pulkitjohar23@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Yashwant Singh Payal 
Designation  Professor 
Affiliation  AIIMS Rishikesh 
Address  Department of Anaesthesiology and Critical Care AIIMS Rishikesh Virbhadra Road Rishikesh

Dehradun
UTTARANCHAL
249203
India 
Phone  9411789762  
Fax    
Email  dryspayal05@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Yashwant Singh Payal 
Designation  Professor 
Affiliation  AIIMS Rishikesh 
Address  Department of Anaesthesiology and Critical Care AIIMS Rishikesh Virbhadra Road Rishikesh


UTTARANCHAL
249203
India 
Phone  9411789762  
Fax    
Email  dryspayal05@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology and Critical Care, AIIMS Rishikesh, Rishikesh, Uttarakhand, India, 249203 
 
Primary Sponsor  
Name  None 
Address  NA 
Type of Sponsor  Other [NA] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pulkit Johar  AIIMS Rishikesh  Level 6 OT Complex, Department of Anaesthesiology, AIIMS Rishikesh, Virbhadra Road, Rishikesh, 249203
Dehradun
UTTARANCHAL 
9877307543

pulkitjohar23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, AIIMS Rishikesh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Melatonin  Group M - Melatonin 0.2 mg per Kg (maximum dose 10mg) as syrup reconstituted with honey to a volume of 5 ml 1 hour before surgery with sips of water 
Comparator Agent  Placebo  Group C - 5 ml honey 1 hour prior to surgery with sips of water 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  8.00 Year(s)
Gender  Both 
Details  American Society of Anaesthesiologists grade I or II paediatric patients (aged from 2 to 8 years) undergoing elective surgical procedure under general anaesthesia (Duration of procedure ranging from 30 minutes to 2 hours). 
 
ExclusionCriteria 
Details  Unwillingness to participation.
Paediatric patients undergoing elective surgical procedure under general anaesthesia from department of Cardiothoracic and Neurosurgery.
Patients with known comorbidities (renal or hepatic derangement, Asthma, TB, etc).
Allergy to Study drugs or Honey.
History of epileptic seizures, psychoactive medications, neurological disorders, or trauma. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess the effect of melatonin premedication on total sevoflurane consumption.
Inhaled sevoflurane requirement (volume%) will be measured to maintain BIS readings between 40 to 50 using Dion method.  
0 minutes, 10 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, 60 minutes, 70 minutes, 80 minutes, 90 minutes, 100 minutes, 110 minutes and 120 minutes after induction of anaesthesia. 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the effect on sedation scores (Ramsay Sedation Scale).  0 minutes, 30 minutes, 60 minutes after premedication and at induction of anaesthesia. 
To assess the effect on anxiety scores (Modified yale preoperative Anxiety Scale).   0 minutes, 30 minutes, 60 minutes after premedication and at induction of anaesthesia. 
To assess the effect on Pain scores (FLACC Scale) during post operative period.  0 minute, 30 minutes, 1 hour, 1.5 hours, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 12 hours, 18 hours, 24 hours in post operative period. 
To assess the Duration of first analgesic requirement in post operative period.
 
Post operative period.
 
To assess the effect on Total analgesic requirement during post operative period. (Injection Fentanyl 0.5 mcg per kg IV).   Till 24 hours in post operative period. 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study explores the use of melatonin as a premedication in pediatric patients undergoing general anesthesia, aiming to assess its impact on the consumption of inhalational sevoflurane. General anesthesia induces a coma-like state, and while effective, its agents come with inherent side effects. Various drugs, including melatonin, have been considered as adjuncts to minimize the required dosage of these agents. Melatonin, a hormone secreted by the pineal gland, has demonstrated anesthetic and antinociceptive properties. Despite its potential benefits, no prior research has systematically investigated the impact of melatonin premedication on sevoflurane consumption in pediatric patients.
The current study addresses this gap by evaluating the effects of melatonin premedication on total sevoflurane consumption, utilizing bispectral index (BIS) to measure the depth of anesthesia and ensure consistent appropriateness throughout the procedure. By bridging this research gap, the study aims to contribute to the advancement of pediatric anesthesiology and enhance the overall quality of care for young patients undergoing surgical procedures.
 
Close